Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.9M
-
Number of holders
-
722
-
Total 13F shares, excl. options
-
70M
-
Shares change
-
+991K
-
Total reported value, excl. options
-
$15.3B
-
Value change
-
+$209M
-
Put/Call ratio
-
0.4
-
Number of buys
-
362
-
Number of sells
-
-340
-
Price
-
$218.80
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q2 2025
826 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q2 2025.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 722 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 70M shares
of 71.9M outstanding shares and own 97.29% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9.32M shares), BlackRock, Inc. (6.6M shares), STATE STREET CORP (3.27M shares), Bank of New York Mellon Corp (3.21M shares), BROWN ADVISORY INC (3.02M shares), Artisan Partners Limited Partnership (2.27M shares), GEODE CAPITAL MANAGEMENT, LLC (1.83M shares), APG Asset Management N.V. (1.66M shares), VAN ECK ASSOCIATES CORP (1.49M shares), and MORGAN STANLEY (1.49M shares).
This table shows the top 722 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.